Audited Results of Supriya Lifescience Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	827.88	696.49	570.37	460.94	530.05
Manufacturing Expenses	29.77	24.80	21.37	20.95	14.07
Personnel Expenses	96.68	80.52	67.64	55.58	49.08
Selling Expenses	0	0	18.54	17.39	16.50
Administrative Expenses	138.26	106.70	53.71	52.09	36.73
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	533.83	435.69	397.39	332.04	316.06
Operating Profit	294.05	260.80	172.98	128.90	213.98
Other Recurring Income	11.49	9.81	10.63	9.49	7.58
Adjusted PBDIT	305.54	270.61	183.61	138.39	221.56
Financial Expenses	1.89	1.69	2.11	3.08	4.20
Depreciation	28.41	20.44	15.81	11.81	10.12
Other Write offs	0	0	0	0	0
Adjusted PBT	275.24	248.48	165.69	123.49	207.25
Tax Charges	65.66	60.52	46.58	33.63	55.44
Adjusted PAT	209.58	187.96	119.11	89.86	151.81
Non Recurring Items	-0.46	0	0	0	0
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	209.12	187.96	119.11	89.86	151.81
Equity Dividend	8.05	6.44	4.83	4.83	4.39
Preference Dividend	0	0	0	0	0
Retained Earnings	983.04	781.97	600.45	486.16	401.13

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article